Cargando…
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
The interaction between the bone marrow microenvironment and malignant hematopoietic cells can result in the protection of leukemia cells from chemotherapy in both myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We, herein, characterized the changes in cytokine expression and the f...
Autores principales: | Lopes, Matheus Rodrigues, Pereira, João Kleber Novais, de Melo Campos, Paula, Machado-Neto, João Agostinho, Traina, Fabiola, Saad, Sara T. Olalla, Favaro, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234038/ https://www.ncbi.nlm.nih.gov/pubmed/28084439 http://dx.doi.org/10.1038/srep40707 |
Ejemplares similares
-
Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
por: Bezerra, Matheus F., et al.
Publicado: (2022) -
AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
por: Koenig, Kristin L., et al.
Publicado: (2020) -
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
por: Tsai, Xavier Cheng-Hong, et al.
Publicado: (2023) -
Differential profile of CDKN1A and TP53 expressions in bone marrow mesenchymal stromal cells from myeloid neoplasms
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2016) -
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
por: Jacoby, Meagan A., et al.
Publicado: (2021)